EP3486193A1 - Umkehrbarer aerosolventilmechanismus und aerosolprodukt mit diesem umkehrbaren ventilmechanismus - Google Patents
Umkehrbarer aerosolventilmechanismus und aerosolprodukt mit diesem umkehrbaren ventilmechanismus Download PDFInfo
- Publication number
- EP3486193A1 EP3486193A1 EP17827264.7A EP17827264A EP3486193A1 EP 3486193 A1 EP3486193 A1 EP 3486193A1 EP 17827264 A EP17827264 A EP 17827264A EP 3486193 A1 EP3486193 A1 EP 3486193A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- invertible
- passage
- contents
- valve
- upright
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000007246 mechanism Effects 0.000 title claims abstract description 29
- 239000000443 aerosol Substances 0.000 title 1
- 238000002347 injection Methods 0.000 claims description 35
- 239000007924 injection Substances 0.000 claims description 35
- 230000009471 action Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 abstract description 4
- 230000000087 stabilizing effect Effects 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract 1
- 239000007789 gas Substances 0.000 description 31
- 239000003795 chemical substances by application Substances 0.000 description 10
- 230000002093 peripheral effect Effects 0.000 description 9
- 230000035515 penetration Effects 0.000 description 8
- -1 polypropylene Polymers 0.000 description 8
- 238000011144 upstream manufacturing Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229920003002 synthetic resin Polymers 0.000 description 3
- 239000000057 synthetic resin Substances 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000009751 slip forming Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 229940102884 adrenalin Drugs 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical compound [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 description 1
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 description 1
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 229960001673 diethyltoluamide Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 239000003822 epoxy resin Substances 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000019837 monoammonium phosphate Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/36—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant allowing operation in any orientation, e.g. discharge in inverted position
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/44—Valves specially adapted therefor; Regulating devices
- B65D83/48—Lift valves, e.g. operated by push action
Definitions
- the present invention relates to a valve acting section (stem hole) by which an operation mode setting operation of an aerosol-type product is used to shift from the previous closed state to an open state to inject the contents in a container body to an outer space region and a contents passage section in an invertible use mode communicating with this.
- the invention relates to an invertible valve mechanism in which the contents passage section is composed of an upright inflow passage and an inverted inflow passage that are continuous in a single straight line-form and a shared invertible passage providing the communication from these common outflow holes to a valve acting section and in which a free fall-type moving valve is provided at a predetermined position of the inverted inflow passage.
- This moving valve is configured so that the inverted inflow passage is set in a shutoff state when the invertible valve mechanism is upright so as to prevent the vaporized gas flowing in the upper part of the container body from entering the upright inflow passage or the shared invertible passage.
- the moving valve may be a ball valve for example.
- the present invention provides an invertible valve mechanism for which the separation relation between this moving valve and the common outflow hole is considered for example to suppress the "gas entrainment" phenomenon of the vaporized gas in the contents to block the so-called intermittent injection of the contents caused by this so that the smooth and continuous injection state can be secured.
- the "gas entrainment” phenomenon is caused, during the upright operation of the invertible valve mechanism, when the inverted inflow passage in the moving valve that should be shut off from the shared invertible passage is displaced in the "dancing" state in an up-and-down direction due to the strength of the contents flowing from the upright inflow passage.
- the "upper” and “lower” directions around the respective components of the invertible valve mechanism show the upper and lower positions in the upright state in Fig. 1 to Fig. 2 .
- the terms “upstream” and “downstream” are not included in the scope of the definitions of the upper and lower positions.
- the up-and-down directions in the respective drawings are also denoted as a "longitudinal” direction and the left-and-right direction is denoted as a "lateral" direction as required.
- the above-described aerosol-type invertible valve mechanism has been conventionally used that consists of the upright inflow passage, the inverted inflow passage, and the shared invertible passage, and this inverted inflow passage includes a free fall ball valve to switch the upright injection/inverted injection (see Patent Publication 1).
- Patent Publication 1 Japanese unexamined patent application publication H6-199376
- the upper end of the common outflow hole is separated from the lower end of the moving valve in the up-and-down direction by a distance of 1.2mm for example.
- the moving valve has been provided in the very vicinity of the upper part of the common outflow hole in the inverted inflow passage that is shared by the upright inflow passage and the inverted inflow passage.
- the moving valve tends to be in the "dancing" state due to the strength of the contents flowing from the upright inflow passage.
- the invertible valve mechanism of the present invention pays attention on not the size or material of the moving valve but on the position of the moving valve in order to eliminate the intermittent injection state of the contents due to the "gas entrainment" in the invertible valve mechanism in which the moving valve is provided on the extended straight line at the contents outflow side of the upright inflow passage.
- the moving valve that shuts off the inverted inflow passage from the downstream-side shared invertible passage in the upright operation mode is provided at a position separated from the upper end of the common outflow hole for the upright inflow passage and the inverted inflow passage by a distance of at least 3.5mm or more desirably a distance of 3.7mm or more.
- This common outflow hole also functions as an inflow section to the shared invertible passage.
- the moving valve to switch ON or OFF the inverted inflow passage is provided at a position upwardly separated from the common outflow hole for the upright inflow passage and the inverted inflow passage by a predetermined distance to thereby block the occurrence of the "dancing" state in which the moving valve in the upright operation mode is displaced by the strength of the upwardly-flowing contents.
- This predetermined distance is "at least 3.5mm or more desirably a distance of 3.7mm or more" as described above.
- the moving valve is provided at a position at the upper side of the common outflow hole separated by a distance about three times longer than the conventional distance of "1.2mm".
- the present invention solves the above disadvantage using an invertible valve mechanism described below.
- the present invention provides an invertible valve mechanism consisting of the above configuration and an aerosol-type product including this.
- the present invention blocks the occurrence of the "dancing" state of the moving valve in the upright operation mode to prevent the "gas entrainment” of vaporized gas in the contents, thus stabilizing the continuous injection state of the contents.
- the common outflow hole is separated, without requiring a particular change of the size of the moving valve itself or the material thereof, from the moving valve by such a distance that prevents the strength of the flowing injection contents from acting on the moving valve, thus providing the efficient use of the components of the invertible valve mechanism.
- the letter A shows an upright inflow passage.
- the letter B shows an inverted inflow passage.
- the letter C shows a shared invertible passage starting from the common outflow hole for the upright inflow passage A and the inverted inflow passage B.
- the letter L shows the interval in the up-and-down direction from the upper end of this common outflow hole to the lower end of the ball valve.
- the reference numeral 1 denotes a depression-type button that can be moved in the up-and-down direction to operate the injection of the contents.
- the reference numeral 1a denotes the well-known button interior passage reaching a contents injection opening.
- the reference numeral 2 denotes a sheath-like stem integrated with the button 1.
- the reference numeral 2a denotes a lateral hole functioning as an output valve with the stem gasket 3 (which will be described later).
- the reference numeral 2b denotes a stem interior passage communicating with the lateral hole 2a and the button interior passage 1a.
- the reference numeral 3 denotes a stem gasket for which the outer part is sandwiched between a housing body 4 and a mounting cup 9 (which will be described later) and the inner end functions as an output valve with the lateral hole 2a.
- the reference numeral 4 denotes a housing body that is attached to the mounting cup 9 (which will be described later) to store the lower part of the stem 2 in the upright state and that defines the shared invertible passage C and the inverted inflow passage B for the contents in the container body.
- the reference numeral 4a denotes an upper sheath-like section of an upper opening that stores a lower part of the stem 2 in the upright state (a substantially-lower part of the lateral hole 2a) and that functions as a space through which the contents are sent and in which the contents are stored.
- the reference numeral 4b denotes a plurality of longitudinal rib-like sections that are provided on the inner circumferential face of an upper sheath-like section 4a and that have thereamong groove-like sections along which the contents are sent.
- the reference numeral 4c denotes a lower sheath-like section of a lower opening that functions as the inverted inflow passage B or as a space region to store the ball valve 7 (which will be described later) in the inverted state.
- the reference numeral 4d denotes the bottom face of the lower sheath-like section 4c in the inverted state that functions as a section to receive the ball valve 7 (which will be described later) in the inverted state.
- the reference numeral 4e denotes the total of two peripheral face openings of the rectangular longitudinal cross section that are formed on the upper column of the lower sheath-like section 4c at an interval of 180 degrees in the circumferential direction and that function as the inflow side of the inverted inflow passage B, respectively.
- the reference numeral 4f denotes the longitudinal space region having an upper opening in the inverted state and having a circular lateral cross section.
- This longitudinal space region has a bottom face part 4d in the inverted state to communicate with a peripheral face opening 4e and guides the up-and-down motion of the ball valve 7 (which will be described later) and functions as a part of the inverted inflow passage B.
- the reference numeral 4g denotes a longitudinal penetration section having a circular lateral cross section.
- the total of 4 longitudinal penetration sections are formed with an interval of 60 degrees in the circumferential direction so as to penetrate, at the respective drum sections between a pair of the peripheral face openings 4e opposed to each other, through the interior of the upper sheath-like section 4a (contents passage groove-like section).
- the reference numeral 4h denotes an annular space region that is set between the inner circumferential face of a lower sheath-like section 4c and the outer peripheral face of an upper cover body 6d (which will be described later) and that functions as an upstream part of the shared invertible passage C.
- the reference numeral 5 denotes a coil spring that is provided between a lower face step of the stem 2 in the upright state and the bottom face part of the upper sheath-like section 4a to bias the stem in the upright state.
- the reference numeral 6 denotes a cylindrical housing cover body having a circular lateral cross section that is engaged with the lower inner face of the housing body 4 in the upright state to define the upstream part of the shared invertible passage C.
- the reference numeral 6a denotes an annular valve seat having a taper face at an inner end of the housing cover body 6 that is closely fitted (abutted) to the ball valve 7 (which will be described later) at the original lower motion position in the upright state.
- the reference numeral 6b denotes an upper central cylindrical section that is continuously formed in the lower direction from the valve seat 6a in the upright state to receive the lower end side of the ball valve 7 in the upright state.
- the reference numeral 6c denotes a cylindrical body that is continuously formed in the lower direction in a large diameter mode from the upper central cylindrical section 6b in the upright state.
- the reference numeral 6d denotes an upper cover body at the upper side of the cylindrical body 6c that constitutes the downstream side of the inverted inflow passage B together with the upper central cylindrical section 6b so that the lower end thereof in the upright state constitutes the downstream end side (downstream side) of the upright inflow passage A.
- the reference numeral 6e denotes a lower cover body at the lower part of the cylindrical body 6c that is attached with a dip tube 8 (which will be described later) to constitute the downstream side of the upright inflow passage A.
- the reference numeral 6f denotes a common outflow hole.
- the total of 2 common outflow holes are formed at the lower end side of the upper cover body 6d with an interval of 180 degrees in the circumferential direction to function as a starting part of the shared invertible passage C in the lateral penetration state.
- the reference numeral 6g denotes an annular collar section that receives the lower end face of the lower sheath-like section 4c in the upright state.
- the reference numeral 7 denotes a ball valve that is closely fitted (abutted) to the valve seat 6a at the lower motion positon in the upright state and that functions as a moving valve abutted to and retained by the bottom face part 4d at the lower motion position in the inverted state of the lower sheath-like section 4c.
- the reference numeral 8 denotes a contents inflow dip tube that is attached to the lower inner circumferential face of the housing cover body 6.
- the reference numeral 9 denotes a mounting cup that is engaged with the housing body 4 to sandwich the stem gasket 3.
- the reference numeral 10 denotes a container body that is attached with the mounting cup 9 and that has an inner space region to store to-be-injected contents and vaporized injection gas.
- the button 1, the stem 2, the housing body 4, the coil spring 5, and the housing cover body 6 are made of synthetic resin such as polypropylene, polyethylene, polyacetal, nylon, or polybutylene terephthalate or metal.
- the stem gasket 3 is made of rubber or synthetic resin.
- the ball valve 7, the mounting cup 9, and the container body 10 are made of metal (e.g., stainless).
- the dip tube 8 is made of synthetic resin.
- the aerosol-type invertible valve mechanism shown in Fig. 1 to Fig. 4 is basically characterized in that the vertical spacing L in the upright state between the upper end of the common outflow hole 6f of the upright inflow passage A and the inverted inflow passage B and the lower end of the ball valve 7 is set to at least 3.5mm or desirably 3.7mm or more.
- this vertical spacing L is increased to have a value larger than a conventional value (e.g., 1.2mm) so as to reduce the influence on the ball valve 7 due to the strength of the contents upwardly flowing from the upright inflow passage A in the upright operation mode.
- a conventional value e.g., 1.2mm
- This reduction of the influence on the ball valve suppresses the vaporized gas in the upper part of the container body in the upright state from passing the ball valve to flow from the inverted inflow passage B to the shared invertible passage C. Specifically, this eliminates the "gas entrainment" of the vaporized gas in the contents in the shared invertible passage C.
- the downward motion of the stem 2 changes the shape of the inner end of the stem gasket 3 to a "bow"-like shape, thereby cancelling the previous valve closed state to the lateral hole 2a.
- This valve cancellation allows, as shown in the drawing, the contents in the lower space region of the container body 10 to pass through the upright inflow passage A and the shared invertible passage C to be injected to the outer space region through the well-known button injection opening.
- the contents in the container body flow through the path composed of "the dip tube 8-the common outflow hole 6f-the annular space region 4h-the longitudinal penetration section 4g-the inner space region of the upper sheath-like section 4a-the lateral hole 2a-the button interior passage 1a".
- the vertical spacing L extending from the upper end of the common outflow hole 6f to the lower end of the ball valve 7 is set to at least 3.5mm or more desirably 3.7mm or more.
- the common outflow hole 6f separated from the ball valve 7 in the up-and-down direction as described above can substantially prevent the ball valve 7 in the upright operation mode from "dancing" due to the strength of the contents upwardly flowing from the upright inflow passage A.
- this spacing can prevent a situation where the vaporized gas enters the shared invertible passage C via the ball valve 7 in the “dancing" state to cause the "gas entrainment" in the contents.
- This suppression of the "gas entrainment" provides the contents injection to the outer space region not in a pulsating flow-like intermittent injection state but in a stable continuous injection state.
- the following table 1 shows the result of the examination of this continuous injection. Specifically, the examination of the injection state was performed based on the total of 11 experimental models prepared to have the vertical spacing L between the upper end of the common outflow hole 6f and the lower end of the ball valve 7 so that the vertical spacing L is changed from 3.0mm to 4.0mm by an increment of 0.1mm.
- L (mm) 3.0-3.4 3.5 3.6 3.7 3.8 3.9
- the occurrence of the "gas entrainment” was examined by visually monitoring the flow of the contents injected to the outer space region via the valve acting section in the open state (the lateral hole 2a and the stem gasket 3). Specifically, the contents injected to the outer space region were visually monitored with regard to whether the contents formed a stable continuous flow or a pulsating flow-like intermittent flow.
- the pulsating flow-like intermittent injection state of the "gas entrainment" may be sufficiently visually monitored by general users.
- the examination result shows, as shown in the table 1, that the vertical spacing L having a different size shows the following different result.
- the vertical spacing L from the upper end of the common outflow hole 6f to the lower end of the ball valve 7 is set to at least 3.5mm or more desirably 3.7mm or more.
- the longitudinal space region 4f was used that had a height of 6.3mm in the up-and-down direction and a diameter of 3.4mm.
- the upper central cylindrical section 6b was used that had a height of 1.0mm in the up-and-down direction and the inner diameter of 2.3mm.
- the cylindrical body 6c was provided between the upper central cylindrical section 6b and the dip tube 8.
- the cylindrical body 6c consisted of a pair of opposed flat surfaces having an interval of 2.8mm and a pair of opposed arc curved surfaces having an inner diameter of 3.3mm therebetween.
- Each of the opposed flat surfaces included therein a common outflow hole 6f having a lateral length of 1.1mm and an inner diameter of 1.5mm.
- the annular space region 4h had a lateral interval of 0.425mm.
- the longitudinal penetration section 4g was used that had a height in the up-and-down direction of 6.7mm, the cross section width of 1.0mm, and a cross section having a depth of 0.6mm.
- the cylindrical body 6c and the annular space region 4h have the direction in the up-and-down direction that is different depending on each experimental model set depending on the value of the vertical spacing L from the upper end of the common outflow hole 6f to the lower end of the ball valve 7.
- This valve cancellation causes, as shown in the drawing, the contents in the upper space region of the container body 10 in the upright state to be sent through the inverted inflow passage B and the shared invertible passage C, thereby injecting the contents to the outer space region through the well-known button injection opening.
- the contents in the container body are allowed to flow through the path of "the peripheral face opening 4e-the longitudinal space region 4f-the inner space region of the upper central cylindrical section 6b-the inner space region of the cylindrical body 6c-the common outflow hole 6f-the annular space region 4h-the longitudinal penetration section 4g-the inner space region of the upper sheath-like section 4a-the lateral hole 2a-the button interior passage 1a".
- the present invention can be applied to aerosol-type products for various applications including cleaning agent, cleanup agent, antiperspirant, coolant, muscular antiphlogistic agent, hairstyling agent, hair treatment agent, hair dye, hair growth agent, cosmetics, shaving foam, foods, droplet-like products (e.g., vitamin), medical products, quasi-pharmaceutical products, paints, agricultural agent, repellents (pesticides), cleaner, deodorizer, laundry starch, urethane foam, fire extinguisher, adhesive agent, or lubricant.
- cleaning agent cleanup agent, antiperspirant, coolant, muscular antiphlogistic agent, hairstyling agent, hair treatment agent, hair dye, hair growth agent, cosmetics, shaving foam, foods, droplet-like products (e.g., vitamin), medical products, quasi-pharmaceutical products, paints, agricultural agent, repellents (pesticides), cleaner, deodorizer, laundry starch, urethane foam, fire extinguisher, adhesive agent, or lubricant
- the contents stored in the container body may be, for example, powder-like matters, oil components, alcohols, surfactant, high molecular compounds, or active ingredients depending on each application.
- Powder-like matters include metal salts powders, inorganic substance powders, or resin powders such as talc, kaolin, aluminum hydroxychloride (aluminum salts), calcium alginate, gold powder, silver powder, mica, carbonate, barium sulfate, cellulose, or the mixtures thereof mixture for example.
- metal salts powders such as talc, kaolin, aluminum hydroxychloride (aluminum salts), calcium alginate, gold powder, silver powder, mica, carbonate, barium sulfate, cellulose, or the mixtures thereof mixture for example.
- Oil components include silicone oil, palm oil, eucalyptus oil, camellia oil, olive oil, jojoba oil, paraffin oil, myristic acid, palmitic acid, stearic acid, linoleic acid, or linolenic acid for example.
- Alcohols include monohydric lower alcohol (e.g., ethanol), monohydric higher alcohol (e.g., lauryl alcohol), or polyalcohol (e.g., ethylene glycol).
- monohydric lower alcohol e.g., ethanol
- monohydric higher alcohol e.g., lauryl alcohol
- polyalcohol e.g., ethylene glycol
- Surfactants include anionic surfactant (e.g., sodium lauryl sulfate), nonionic surfactant (e.g., polyoxyethylene oleylether), amphoteric surfactant (e.g., lauryldimethylaminoacetic acid betaine), or cationic surfactant (e.g., alkyl trimethylammonium chloride) for example.
- anionic surfactant e.g., sodium lauryl sulfate
- nonionic surfactant e.g., polyoxyethylene oleylether
- amphoteric surfactant e.g., lauryldimethylaminoacetic acid betaine
- cationic surfactant e.g., alkyl trimethylammonium chloride
- High molecular compounds include methyl cellulose, gelatin, starch, or casein for example.
- Active ingredients depending on the respective applications include antiinflammatory agent (e.g., methyl salicylate, indomethacin), sterilization chemicals (e.g., sodium benzoate, cresol), insect pests repellents (e.g., pyrethroid, diethyltoluamide), antiperspirant (e.g., zinc oxide), refreshing medicine (e.g., camphor, menthol), antiasthmatic agent (e.g., ephedrine, adrenalin), sweetener (e.g., sucralose, aspartame), adhesive agent or paints (e.g., epoxy resin, urethane), dyes (e.g., paraphenylenediamine, aminophenol), extinguishing agent (e.g., ammonium dihydrogen phosphate, sodium bicarbonate, potassium) for example.
- antiinflammatory agent e.g., methyl salicylate, indomethacin
- sterilization chemicals e.g., sodium benzoate, cresol
- agents other than the above contents can include suspension, ultraviolet absorber, emulsifier, moisturizing agent, antioxidant, or sequestering agent for example.
- Contents pressurizing agent in an aerosol-type product includes carbon dioxide gas, nitrogen gas or the mixed gas thereof, compressed gas (e.g., compressed air), and LPG, DME, or liquefied gas (e.g., fluorohydrocarbon gas) for example.
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Nozzles (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016140662 | 2016-07-15 | ||
PCT/JP2017/020088 WO2018012131A1 (ja) | 2016-07-15 | 2017-05-30 | エアゾールタイプの正倒立バルブ機構およびこの正倒立バルブ機構を備えたエアゾール式製品 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3486193A1 true EP3486193A1 (de) | 2019-05-22 |
EP3486193A4 EP3486193A4 (de) | 2020-04-29 |
EP3486193B1 EP3486193B1 (de) | 2021-08-11 |
Family
ID=60953049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17827264.7A Active EP3486193B1 (de) | 2016-07-15 | 2017-05-30 | Umkehrbarer aerosolventilmechanismus und aerosolprodukt mit diesem umkehrbaren ventilmechanismus |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3486193B1 (de) |
JP (1) | JPWO2018012131A1 (de) |
CN (1) | CN109476413B (de) |
ES (1) | ES2898378T3 (de) |
TW (1) | TWI633237B (de) |
WO (1) | WO2018012131A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108380428B (zh) * | 2018-05-15 | 2020-03-20 | 佛山安豪科技服务有限公司 | 一种喷枪的喷壶结构 |
KR20220062491A (ko) * | 2019-09-13 | 2022-05-17 | 가부시키가이샤 미타니 밸브 | 내용물 분출 유닛 및 분출 용기 |
BE1027882B1 (nl) * | 2020-05-15 | 2021-07-12 | Altachem | Steel van een ventiel |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3985271A (en) * | 1975-06-06 | 1976-10-12 | Glasrock Products, Inc. | Foam generating and dispensing device |
DE2817393C2 (de) * | 1978-04-20 | 1981-09-17 | Perfect-Valois-Ventil Gmbh, 4600 Dortmund | Sprühventil für Aerosoldosen |
DE3025725C2 (de) * | 1980-07-08 | 1985-11-07 | Deutsche Präzisions-Ventil GmbH, 6234 Hattersheim | Sprühventilanordnung |
FR2551828B1 (fr) * | 1983-09-12 | 1986-08-08 | Valvole Aerosol Res Italia | Valve retournable pour la distribution de liquide conditionne sous pression |
JP2691840B2 (ja) * | 1992-12-01 | 1997-12-17 | 誠一 北林 | 正立使用、倒立使用の両使用可能な高速充填用エアゾールバルブ |
US5350088A (en) * | 1993-09-13 | 1994-09-27 | Summit Packaging Systems, Inc. | Invertible aerosol valve |
US5803319A (en) * | 1996-01-19 | 1998-09-08 | Summit Packaging Systems, Inc. | Invertible spray valve and container containing same |
US5979712A (en) * | 1997-10-24 | 1999-11-09 | Monturas, S.A. | Upright/inverted sprayer |
JPH11171228A (ja) * | 1997-12-09 | 1999-06-29 | Lion Corp | 正/倒立注出容器 |
WO2000015349A1 (fr) * | 1998-09-11 | 2000-03-23 | Yoshino Kogyosho Co., Ltd. | Receptacle de pulverisation de liquide de type gachette fonctionnant a la fois en position verticale et en position inversee |
EP1149776A3 (de) * | 2000-03-03 | 2004-01-02 | de Schrijver, Aster | Ventil |
JP2001276683A (ja) * | 2000-03-28 | 2001-10-09 | Mitani Valve Co Ltd | 正倒立併用の内容物放出機構 |
JP2003072868A (ja) * | 2001-08-29 | 2003-03-12 | Mitani Valve Co Ltd | エアゾール容器用正倒立バルブ |
JP5288410B2 (ja) * | 2009-04-27 | 2013-09-11 | 株式会社三谷バルブ | 正倒立バルブ機構および正倒立バルブ機構を備えたエアゾール式製品 |
JP6172844B2 (ja) * | 2013-04-10 | 2017-08-02 | 株式会社三谷バルブ | 噴射用ガス充填対応の正倒立バルブ機構およびこの正倒立バルブ機構を備えたエアゾール式製品 |
CN205341105U (zh) * | 2015-12-15 | 2016-06-29 | 上溢精密股份有限公司 | 可倒立使用的喷雾器 |
-
2017
- 2017-05-30 JP JP2018527431A patent/JPWO2018012131A1/ja active Pending
- 2017-05-30 ES ES17827264T patent/ES2898378T3/es active Active
- 2017-05-30 EP EP17827264.7A patent/EP3486193B1/de active Active
- 2017-05-30 WO PCT/JP2017/020088 patent/WO2018012131A1/ja active Application Filing
- 2017-05-30 CN CN201780043750.9A patent/CN109476413B/zh active Active
- 2017-06-27 TW TW106121390A patent/TWI633237B/zh active
Also Published As
Publication number | Publication date |
---|---|
ES2898378T3 (es) | 2022-03-07 |
EP3486193B1 (de) | 2021-08-11 |
TWI633237B (zh) | 2018-08-21 |
CN109476413A (zh) | 2019-03-15 |
WO2018012131A1 (ja) | 2018-01-18 |
TW201804082A (zh) | 2018-02-01 |
EP3486193A4 (de) | 2020-04-29 |
JPWO2018012131A1 (ja) | 2019-05-23 |
CN109476413B (zh) | 2020-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3486193B1 (de) | Umkehrbarer aerosolventilmechanismus und aerosolprodukt mit diesem umkehrbaren ventilmechanismus | |
KR101702172B1 (ko) | 액츄에이터 도립 정량 분사기구 및 이 액츄에이터 도립 정량 분사기구를 구비한 에어졸식 제품 | |
US8201757B2 (en) | Flow rate regulator unit and aerosol type product with flow rate regulator unit | |
JP7529854B2 (ja) | 害虫防除用定量噴射型エアゾール製品および害虫防除方法 | |
JP2006289302A (ja) | チップストップ機構,チップストップ機構を備えたポンプ式製品および、チップストップ機構を備えたエアゾール式製品 | |
JP2014205494A (ja) | 噴射用ガス充填対応の正倒立バルブ機構およびこの正倒立バルブ機構を備えたエアゾール式製品 | |
JP4755442B2 (ja) | 粉末含有エアゾール製品 | |
CN106029523B (zh) | 内容物释放状态切换机构、具备该内容物释放状态切换机构的喷雾式制品和泵式制品 | |
CN112469640B (zh) | 内容物喷射操作按钮和具备该内容物喷射操作按钮的气溶胶式产品 | |
JP6762141B2 (ja) | 内容物噴射操作用ボタンおよびこの内容物噴射操作用ボタンを備えたエアゾール式製品 | |
JP4210542B2 (ja) | 時限式薬液定量供給装置 | |
JP2005074341A (ja) | エアゾール容器用噴射ノズル | |
JP6931541B2 (ja) | エアゾール容器用のアクチュエーター、エアゾールバルブ及びエアゾール製品 | |
JP6853923B2 (ja) | 内容物放出構造ならびにこの内容物放出構造を備えたエアゾール式製品およびポンプ式製品 | |
WO2023145977A1 (ja) | 定量噴射機構および、この定量噴射機構を備えたエアゾール式製品 | |
JP5477956B2 (ja) | 内容物放出量切換え機構ならびにこの機構を備えたエアゾール式製品およびポンプ式製品 | |
JP6671760B2 (ja) | 内容物放出機構およびこの内容物放出機構を備えたエアゾール式製品 | |
JP2002080080A (ja) | 連続自動噴射が可能なエアゾール容器 | |
WO2023080095A1 (ja) | 内容物噴射機構およびこの内容物噴射機構を備えたエアゾール式製品 | |
JP2004305504A (ja) | エアゾール式洗眼剤 | |
JP7166269B2 (ja) | 定量噴射型エアゾール製品および定量噴射型エアゾール製品の噴射方法 | |
JP2008265794A (ja) | エアゾール容器のガス抜き機構および、このガス抜き機構を備えたエアゾール式製品 | |
JP2005306459A (ja) | ガス抜き機構およびエアゾール式製品 | |
JPS6231164Y2 (de) | ||
JP2000185782A (ja) | エアゾール製品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190207 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200330 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B65D 83/36 20060101AFI20200324BHEP Ipc: B05B 9/04 20060101ALI20200324BHEP Ipc: B65D 83/44 20060101ALI20200324BHEP Ipc: B65D 83/48 20060101ALI20200324BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20210304 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017043975 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Ref country code: AT Ref legal event code: REF Ref document number: 1419188 Country of ref document: AT Kind code of ref document: T Effective date: 20210915 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20210811 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1419188 Country of ref document: AT Kind code of ref document: T Effective date: 20210811 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211213 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211111 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211111 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211112 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2898378 Country of ref document: ES Kind code of ref document: T3 Effective date: 20220307 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602017043975 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20220512 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20220531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220530 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220531 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220530 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20170530 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240521 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240521 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240627 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CZ Payment date: 20240517 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240528 Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210811 |